<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">It is perhaps unsurprising, given the passage of time, that an understanding of viral oculotropism from the 1918 influenza epidemic has faded. Yet if SARS-CoV-2 oculotropism is confirmed, this invasion entry point also represents an opportunity for intervention. Given the potential toxicity of apparently efficacious drugs and issues relating to drug bioavailability, initially in the upper airways and respiratory system, local, topical therapy offers potential significant advantages.</p>
